Study Bolsters Patient-Controlled Analgesia for Cancer Pain

Patient-controlled analgesia (PCA) IV hydromorphone titration provides quicker analgesic effect, higher patient satisfaction and a similar tolerability compared with non-PCA administration in patients with severe cancer pain, according to a study presented at the 2020 annual meeting of the American Society of Clinical Oncology (abstract 12078). The findings come from a phase 3, randomized clinical trial involving 214 patients.